Regulating "higher risk, no direct benefit" studies in minors

American Journal of Bioethics

Volumn 11, Issue 6, 2011, Pages 29-31

  Westra, Anna E ^a   Wit, Jan M ^a   Sukhai, Rám N ^a   de Beaufort, Inez D ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADOLESCENT; ARTICLE; CLINICAL TRIAL (TOPIC); ETHICS; HUMAN; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMED CONSENT; JUVENILE; LEGAL ASPECT; METHODOLOGY; PARTICIPATORY RESEARCH; PRIMARY PREVENTION; RISK;

ADOLESCENT; AIDS VACCINES; CLINICAL TRIALS AS TOPIC; COMMUNITY-BASED PARTICIPATORY RESEARCH; HIV INFECTIONS; HUMANS; INFORMED CONSENT BY MINORS; MINORS; NONTHERAPEUTIC HUMAN EXPERIMENTATION; PRIMARY PREVENTION; RISK;

EID: 79959201430     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265161.2011.566669     Document Type: Article

References (9)

1. Boots, I., R.N. Sukhai, R. H. Klein, et al. 2007. Stimulation programs for pediatric drug research-Do children really benefit? European Journal of Pediatrics 166(8): 849-855.
2. De Wildt, S. N., and C. A. Knibbe. 2009. Knowledge of developmental pharmacology and modeling approaches should be used to avoid useless trials in children. European Journal of Clinical Pharmacology 65(8): 849-850.
3. Emanuel, E. J.,D. Wendler, and C. Grady. 2000. What makes clinical research ethical? Journal of the American Medical Association 283(20): 2701-2711.
4. Kopelman, L. 2004. Minimal risk as an international standard in research. Journal of Medicine and Philosophy 29(3): 351-738.
5. Ramsey, P. 1976. The enforcement of morals: Nontherapeutic research on minors. Hastings Center Report 6(4): 21-30.
6. Redmon, R. B. 1986. How minors can be respected as ends yet still be used as subjects in non-therapeutic research. Journal of Medical Ethics 12(2): 77-82.
7. Snyder, J., C. Miller, and G. Gray. 2011. Relative versus absolute standards for everyday risk in adolescent HIV prevention trials: Expanding the debate. American Journal of Bioethics 11(6): 5-13.
8. U.S. Department of Health and Human Services. 1983. Protections forminors involved as subjects in research (45 CFR part 46, subpart D). Federal Register 48: 9814-9820.
9. Wendler, D. S. 2010. The ethics of pediatric research. New York: Oxford University Press.